Advanced Filters
noise
Found 64,920 clinical trials
J Jillian Kifell, MSc

Increasing Family Engagement in Critical Care

The primary aim of this trial is to evaluate if the NGAGE tool improves care engagement in family members of ICU patients. The secondary objectives are to assess if the NGAGE tool improves communication, care satisfaction, psychological symptoms, and quality of life in family members of ICU patients. The NGAGE …

18 years of age All Phase N/A
F Fernanda Gabler Trisotti, PhD

Cycle Nation Communities: Increasing Cycling in Glasgow

This randomised controlled trial will evaluate the effects of a 9-week multi-component group-based cycling programme (Cycle Nation) versus a standard single cycle training session on self-reported cycling, health and wellbeing outcomes. Participants are adults that do not regularly cycle, who will be randomly allocated to each arm of the study. …

18 years of age All Phase N/A
Q Qinghe Zhou

Feasibility of Deep Inspiratory Internal Jugular Vein Variability in Guiding Preoperative Fluid Replacement

Compare the incidence of hypotension during the propofol-induced period between the internal jugular vein variability-guided fluid infusion group and the conventional fluid infusion group through a fluid infusion experiment before anesthesia induction, so as to evaluate the feasibility of using the internal jugular vein variability under deep inspiration to guide …

60 - 80 years of age All Phase N/A
L Liao Wei

FOLFOX-HAIC as Conversion Treatment for Initially Unresectable Colorectal Liver Metastasis

Try FOLFOX-HAIC combining bevacizumab or cetuximab for initially unresectable colorectal liver metastasis patients to increase the conversion to resection rate to improve long-term survival outcomes

18 - 75 years of age All Phase 2
M Mingzhi Zhang, Pro.DR

"Selinexor+Pegaspargase+Dexamethasone"in Ⅰ/Ⅱ NKTCL

evaluate the efficacy and safety of "Selinexor+pegaspargase+dexamethasone" in early stage NK/ T-cell lymphoma

18 - 70 years of age All Phase 1/2
S Soo Young Lee

Phase 3 Study to Evaluate the Immunogenicity and Safety of Inactived Split Influenza Vaccine in Healthy Korea Infants

The purpose of this study is to evaluate the safety and immunogenicity of IL-YANG Inactivated Split Influenza Vaccine (IL-YANG Quadrivalent Seasonal Influenza Vaccine) in healthy infants from 6 months to under 3 years of age(≥ 6 months and < 3 years)

6 - 3 years of age All Phase 3
N Nina Vaaranen-Valkonen, M.Soc.Sc

ReDirection / Self-Guided ICBT to Reduce the Risk of Child Sexual Abuse Material (CSAM) Use

The creation and distribution of child sexual abuse material (CSAM) is a large-scale global problem. CSAM is sometimes referred to as child pornography. It includes images, videos, live-streaming, and any other material that depicts sexual acts with a child or adolescent (i.e., a person under the age of 18). It …

18 years of age All Phase N/A
S Shuxia Yao

Individual Differences in Cognitive Control Predict Real-time fMRI Neurofeedback Performance

The goal of this study is to investgate whether individual differences of cognitive control capacity could predict neurofeedback performance and the behavioral effects resulting from successful anterior insula regulation via interoceptive strategy.

18 - 35 years of age All Phase N/A
S Shahbaz Saqib, BDS

Regenerative Endodontic Therapy in Cases of Irreversible Pulpitis

Root canal therapy (RCT) is a classical and effective treatment that is currently utilised in dental practice, offering high success rates for pulp and periapical diseases; however, teeth after RCT are susceptible to altered pulp defence and sensory function, even fractures, as a consequence of pulp loss. Furthermore, several studies …

18 - 35 years of age All Phase N/A
J Jessica Vincent, MD

Orexin Receptor Antagonism and Sleep in Stimulant Use Disorder

The purpose of this study is to determine the effects of suvorexant (SUVO), on sleep, stress, and drug craving during early abstinence from stimulants and to determine the effects of treatment (SUVO vs. treatment as usual (TAU)) on post-treatment (Days 13-30) residential program length of stay (LOS) and completion rate.

18 - 65 years of age All Phase 2

Simplify language using AI